Results 61 to 70 of about 9,436 (212)
Amblyomma sculptum showed a plasmatocyte‐dominant haemocyte profile. Beauveria bassiana increased plasmatocytes and reduced granulocytes, whereas Metarhizium robertsii did not cause significant changes. Amblyomma americanum showed a granulocyte‐dominant haemocyte profile. Beauveria bassiana reduced total haemocytes and granulocytes. B.
Cárita de Souza Ribeiro‐Silva +7 more
wiley +1 more source
Recent advances in understanding Crimean–Congo hemorrhagic fever virus [PDF]
Crimean-Congo hemorrhagic fever virus (CCHFV) is a widely distributed hemorrhagic fever virus and the cause of hemorrhagic disease in Africa, Southern and Eastern Europe, the Middle East, India and Asia. Recent emergence of CCHFV into Spain indicates that the geographic range of this virus is expanding and the presence of its tick vector in several ...
David W. Hawman, Heinz Feldmann
openaire +2 more sources
Crimean-Congo Hemorrhagic Fever in Bulgaria
We report the epidemiologic characteristics of Crimean-Congo hemorrhagic fever in Bulgaria, as well as the first genetic characterization of the virus strains circulating in the country in 2002–2003 that caused disease in humans.
Anna Papa +3 more
doaj +1 more source
ABSTRACT Introduction Crimean‐Congo haemorrhagic fever virus (CCHFV) is a tick‐borne zoonotic pathogen of major public health importance in Africa. Although CCHFV exposure has been reported in several livestock species in Nigeria, data on equids remain limited despite their extensive involvement in livestock movement and trade.
David O. Ehizibolo +14 more
wiley +1 more source
Crimean-Congo Hemorrhagic Fever [PDF]
The Crimean-Congo Hemorrhagic Fever (CCHF) is a tick-borne infectious viral disease in the family Bunyaviridae. The disease was first characterized in the Crimea in 1944 and given the name Crimean hemorrhagic fever. CCHF was then later recognized in 1969
Ninan, Reuben
core +2 more sources
AGILE (NCT04746183) is a Phase Ib/IIa platform, evaluating candidates to treat COVID‐19. Candidate Specific Trial 6 evaluated the safety and optimal dose of a novel intravenous formulation of favipiravir in a dose‐escalating, open‐label, randomized, controlled, Bayesian adaptive Phase Ib trial.
Tim Rowland +48 more
wiley +1 more source
Crimean–Congo Hemorrhagic Fever Virus: Progress in Vaccine Development
Crimean-Congo hemorrhagic fever virus (CCHFV), a member of the Nairoviridae family and Bunyavirales order, is transmitted to humans via tick bites or contact with the blood of infected animals. It can cause severe symptoms, including hemorrhagic fever, with a mortality rate between 5 to 30%.
openaire +4 more sources
This study was conducted in order to identify genetic markers of pathogens (RNA, 16S rRNA or DNA) of natural-focal infectious diseases of bacterial, viral and rickettsial origin in suspensions of Ixodidae ticks collected in certain regions of the ...
E. V. Naidenova +15 more
doaj +1 more source
A case of brucellosis mimicking Crimean-Congo hemorrhagic fever
Summary: Brucellosis is a zoonotic disease caused by Brucella spp. that is transmitted to humans by the ingestion of unpasteurized milk and other dairy products from infected animals or through close contact with secretions.
Ozge Metin +6 more
doaj +1 more source
Some evidences about Crimean Congo Hemorrhagic Fever [PDF]
[No abstract ...
Abbasi, A., Besharat, S., Jabbari, A.
core

